Diagnostic and Treatment Barriers

Risks & contraindications

Other

Highlighted claims

• The qualitative analysis identified six interrelated barriers operating at patient, provider, institutional, and policy levels. — Treatment adherence, survival outcomes and barriers to care of non-Hodgkin lymphoma in Northwest Ethiopia: a mixed-methods study
• Patients often lacked awareness of early lymphoma symptoms such as painless lymph node swelling, weight loss, and fatigue. — Treatment adherence, survival outcomes and barriers to care of non-Hodgkin lymphoma in Northwest Ethiopia: a mixed-methods study
• Lymphoma was frequently misdiagnosed as tuberculosis or bacterial infection at the primary care level. — Treatment adherence, survival outcomes and barriers to care of non-Hodgkin lymphoma in Northwest Ethiopia: a mixed-methods study
• Limited diagnostic infrastructure made accurate subtyping and treatment selection difficult. — Treatment adherence, survival outcomes and barriers to care of non-Hodgkin lymphoma in Northwest Ethiopia: a mixed-methods study
• Chemotherapy continuity was affected by frequent stock-outs of essential drugs, especially rituximab. — Treatment adherence, survival outcomes and barriers to care of non-Hodgkin lymphoma in Northwest Ethiopia: a mixed-methods study
• Financial hardship was a major barrier to diagnosis and treatment continuity. — Treatment adherence, survival outcomes and barriers to care of non-Hodgkin lymphoma in Northwest Ethiopia: a mixed-methods study
• Workforce shortages reduced capacity for close monitoring of patients. — Treatment adherence, survival outcomes and barriers to care of non-Hodgkin lymphoma in Northwest Ethiopia: a mixed-methods study